Exatecan-mpGly-Asn-Asn- (βAla)
Exatecan-mpGly-Asn-Asn- (βAla) (Compound 10b) is a conjugate of Exatecan (HY-13631) and a linker. Exatecan-mpGly-Asn-Asn- (βAla) can be used to synthesize ADCs, such as α-HER2_mpGlyAsnAsn (β-Ala) _Exatecan. Exatecan-mpGly-Asn-Asn- (βAla) can also be used in tumor research[1].
Product Specifications
CAS Number
[3076725-07-7]
UNSPSC
12352211
Target
Drug-Linker Conjugates for ADC
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(C=CC1=O)N1CCC(NCC(N[C@@H](CC(N)=O)C(N[C@@H](CC(N)=O)C(NCCC(N[C@@H]2C3=C4C(C(N5C4)=CC([C@](O)(C(OC6)=O)CC)=C6C5=O)=NC7=CC(F)=C(C)C(CC2)=C73)=O)=O)=O)=O)=O
Molecular Formula
C44H47FN10O13
Molecular Weight
942.90
References & Citations
[1]Ojo VT, et al. Legumain-Cleavable Top1i Antibody-Drug Conjugates without Self-Immolative Spacers Demonstrate Potent Antitumor Activity. J Med Chem. 2025 Dec 11;68 (23) :25505-25522.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
